Torrent Pharma has reported results for first quarter ended June 30, 2026 (Q1FY27).
The company has reported 10.71% fall in its net profit at Rs 492 crore for the quarter ended June 30, 2026 as compared to Rs 551 crore for the same quarter in the previous year. However, total income of the company has increased 58.45% at Rs 4,137 crore for Q1FY27 as compared to Rs 2,611 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 3.28% rise in its net profit at Rs 566 crore for Q1FY27 as compared to Rs 548 crore for the same quarter in the previous year. The total income of the company has increased 56.29% at Rs 4,909 crore for Q1FY27 as compared to Rs 3,141 crore for the corresponding quarter previous year.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1960.00 |
| Dr. Reddys Labs. | 1160.65 |
| Cipla | 1450.00 |
| Lupin | 2376.00 |
| Zydus Lifesciences | 1118.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: